Home » Topics » Regulatory

Regulatory
RSS

Irinotecan approved as first-line treatment for advanced colorectal cancer in Europe

July 29, 1999

FDA approves pediatric formulation of Topamax

July 28, 1999

Fujisawa initiates enrollment in phase III RA trial of Prograf

July 27, 1999

OraSolv Zomig receives first regulatory approval in Sweden for migraine

July 22, 1999

Tachykinin antagonists now proposed for attention deficit disorders

July 22, 1999

Use of zonisamide for neurodegenerative disorders

July 21, 1999

Priority review status granted to Immunex's MS drug

July 21, 1999

PDT with Photofrin cleared in Canada for certain forms of lung cancer

July 19, 1999

FDA clears pioglitazone for type II diabetes

July 19, 1999

New label sought for Enbrel in early, active RA

July 16, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...